Crunching the numbers for HURA... Refresh in a moment for the full analysis.

TuHURA Biosciences, Inc./NV (HURA)

weak

$2.27

Updated: 2026-04-13

TradeApes Score

reduce

Financial Strength

35 Weak

Operating Trend

40 Weak

Valuation

40 Weak

Capital Allocation

50 Mixed

Risk

80 Strong

Key Findings

− Weak liquidity — current assets below current liabilities

See the full analysis

Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.

Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.